Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $1B+, returning 12,325.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,325.15% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,634.05% |
Diginex Limited Ordinary Shares (DGNX) | 1,404.23% |
Palvella Therapeutics (PVLA) | 749.1% |
Cidara Therapeutics (CDTX) | 713.91% |
Terns Pharmaceuticals (TERN) | 697.87% |
Celcuity LLC (CELC) | 696.14% |
Newegg Commerce (NEGG) | 675% |
Nanobiotix (NBTX) | 629.9% |
Americas Silver (USAS) | 507.37% |
Hycroft Mining (HYMC) | 492.92% |
Sandisk (SNDK) | 488.08% |
TMC the metals (TMC) | 482.46% |
Nutex Health (NUTX) | 477.24% |
Olema Pharmaceuticals (OLMA) | 458.28% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 449.43% |
Cogent Biosciences (COGT) | 433.04% |
GRAIL, LLC (GRAL) | 409.65% |
Almonty Industries Inc Common Shares (ALM) | 369.44% |
EchoStar (SATS) | 364% |
Planet Labs PBC (PL) | 345.97% |
Aris Mining (ARMN) | 342.54% |
Anywhere Real Estate (HOUS) | 334.23% |
Bloom Energy (BE) | 321.95% |
